This goal can be realized through studies that may provide accurate assessment through multivariable analyses of CYP2A6 genes variants in correlation with nicotine dependence and withdrawal syndrome, other genes, and different forms of therapies [42]. This evidence concerns the gene CYP2A6 and substance withdrawal syndrome.